| India | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $550 | from $2,430 | from $2,500 |
| CAR T-cell therapy | from $50,000 | from $150,000 | from $350,000 |
| Bone marrow transplantation | from $15,000 | from $36,000 | from $140,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma treatment journey.
Head of Bone Marrow Transplant Department at BLK Hospital – Dr. Choudhary specializes in allogeneic transplants and graft-versus-host disease.
Dr. Kalashetty specializes in oncohematology and bone marrow transplantation – key areas for lymphoma treatment at Manipal Hospitals.
Pediatric hematologist-oncologist specializing in lymphoma care at Global Hospital Mumbai.
Written by Anna Leonova
Written by Halina Shubala
Lymphoma treatment in India achieves success rates between 60% and 95%. Outcomes for early-stage Hodgkin lymphoma often exceed 90% survival. Indian oncology centers use advanced protocols like CAR T-cell therapy and bone marrow transplantation. These facilities maintain standards comparable to global benchmarks for cancer care.
Bookimed Expert Insight: High-volume centers like Global Hospital Chennai and Manipal Hospitals handle thousands of oncology cases annually. Data shows that doctors like Dr. Dharma Choudhary and Dr. Rahul Bhargava have performed over 850 and 1,000 transplants respectively. This deep procedural experience is a major driver of India's high success rates in complex hematology.
Patient Consensus: Patients emphasize that starting treatment at stage I or II leads to 90% remission. Many recommend tracking PET scans closely during the second year when most relapses occur.
CAR-T cell therapy is available in India for treating specific lymphomas and leukemias. The country utilizes indigenous therapies like NexCAR19 and Qartemi at specialized oncology centers. These approved treatments target relapsed or refractory B-cell malignancies. Leading facilities in Mumbai, Delhi, and Bangalore provide this advanced immunotherapy.
Bookimed Expert Insight: India has become a global hub for cell therapy by commercializing its own CAR-T products. Data shows that domestic manufacturing allows centers like Manipal Hospitals to serve massive patient volumes. Clinicians like Dr. Dharma Choudhary at BLK highlight the importance of high-volume transplant experience. This infrastructure supports the complex apheresis and infusion protocols required for CAR-T success.
Patient Consensus: Patients note that while local versions are more affordable, manufacturing logistics can still take 4 to 6 weeks. Many emphasize the need to choose hospitals in major cities to ensure stable power and medical support.
Top Indian hospitals for lymphoma care include Manipal Hospitals, Fortis Gurgaon, and Medanta Hospital. These centers offer advanced CAR-T cell therapy and complex bone marrow transplants. Facilities often hold JCI or NABH accreditations. Specialized hematology-oncology units provide comprehensive diagnostic biopsies and targeted chemotherapy protocols.
Bookimed Expert Insight: Lymphoma patients often find the best value at multidisciplinary hubs like Global Hospital Chennai or Manipal Hospitals. These clinics combine high patient volumes with multiple ISO and Newsweek rankings. Our data shows these larger networks manage complex blood cancers across 15+ locations. This scale ensures consistent access to sub-specialists and the latest diagnostic equipment.
Patient Consensus: Patients note that private hospitals like Apollo and Fortis provide faster access to targeted therapies and better comfort. Those with complex cases frequently recommend starting at high-volume centers to ensure the oncology team manages over 500 cases annually.